Navigation Links
Measuring artery repair cells could become new heart disease test

A more accurate method for measuring blood levels of specialized cells that circulate in the bloodstream and repair damage to the arterial lining has been discovered by Duke University Medical Center cardiologists. These cells, known as endothelial progenitor cells (EPC), are produced in the bone marrow and travel to the site of arterial damage.

The researchers said that tests for EPCs could be used to assess a patient's degree of coronary artery disease or risks for suffering a heart attack, and they could become as routine as the cholesterol and lipid tests cardiologists now commonly use. Patients with lower levels of circulating EPCs would be less able to repair cardiac damage. Thus, they would be those with greater disease and at greater risk for a cardiac event, said the Duke cardiologists

Additionally, the researchers found that the EPC levels correlated with the degree of coronary artery disease. Patients with no coronary artery disease had about 70 percent more EPCs than those who had disease in several coronary vessels.

Recent Duke research has linked the progression of the artery-clogging disease atherosclerosis to the inability of EPCs to continuously repair damage to the arterial lining. Duke researchers have shown that -- while risk factors such as poor diet, smoking, high cholesterol levels and inactivity are important in the development of atherosclerosis --the disease progresses as the body's loses its intrinsic ability to repair and rejuvenate itself.

Current methods for measuring EPCs ?which can represent as few as one out of 10,000 cells in a given blood sample ?are subjective and time-consuming, the researchers said. As an indicator of EPC cell levels, the new method uses measurements of the amount of a detoxification enzyme, known as aldehyde dehydrogenase (ALDH), which is produced in high amounts by EPCs.

"Our studies have shown that using ALDH activity to determine the numbers of EPCs in a blood sample mi ght be a better method for identifying and measuring EPC levels in patients with heart disease than currently used methods," said Duke cardiologist Thomas Povsic, M.D. Povsic presented the results of the Duke research March 12, 2006, during the 55th annual scientific sessions of the American College of Cardiology in Atlanta.

"In order for the use of EPC to become practical in human patients, we need an assay that is quick, reliable and accurate," said Povsic. "Since there are so few EPCs circulating, we literally need a method that can find a needle in a haystack. Our tests so far measuring using ALDH activity to measure EPCs represents a novel approach to solving this problem.

"The paradigm of atherosclerosis is changing. In the past we only thought of the risk factors we could measure, such as cholesterol, lipids and some new markers like c-reactive protein," Povsic continued. "We're learning that atherosclerosis is a balancing act between damage and repair, and now we may have a test that gives us insight into the repair portion of the equation."

"If the results of this study are borne out, measuring EPCs could be a better test for defining an individual patient's risk for heart disease," Povsic said. "Theoretically, patients who are found to have low levels of EPCs would be those patients we may want to treat more aggressively."

ALDH is produced in high amounts by stem cells in the bone marrow as part of the process of maintaining the longer lifespans of these cells. Researchers have used ALDH assays to measure the number of stem cells in the bone marrow, so the team has extended this assay to detect levels of EPCs, which are progenitor cells in the blood which may repair one's arteries.

Current methods for measuring EPCs are conducted in the laboratory and are laborious and time-consuming, Povsic said. Researchers first remove all the immune system cells from a blood sample, then culture the remaining cells and then count individual of EPC colonies that grow. The new system permits researchers to gauge the number of EPCs based by identifying those cells with a high amount of ALDH activity.

The Duke researchers based their studies on analysis of blood samples taken from 229 patients who underwent a cardiac catheterization at Duke University Hospital. The researchers found a close relationship between the amount of coronary artery disease and levels of EPCs in the blood as determined using the ALDH test.


Source:Duke University Medical Center

Related biology news :

1. Measuring the impact of post-genomics on Mediterranean populations
2. Measuring hormone cuts antibiotic use in half in pneumonia patients
3. Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol
4. Measuring hidden parasites in falciparum malaria
5. Columbia study shows widely used artery clearing device does not help patients during heart attack
6. Heart repair gets new muscle
7. Nano-bumps could help repair clogged blood vessels
8. New understanding of DNA repair may pave way to cancer treatments
9. Researchers pioneer new gene therapy technique using natural repair process
10. Circulating stem cells play small role in lung repair
11. Muscle repair: Making a good system better, faster; implications for aging, disease
Post Your Comments:

(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer ... that they have entered into a multiyear collaboration to identify and characterize novel ... additional tools for gene editing across all applications. , Under the terms of ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract research, ... improve patient outcomes and quality of life, will now be offering its impurity ... to new regulatory requirements for all new drug products, including the finalization of ...
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... Md. (PRWEB) , ... October 11, 2017 , ... ... digital pathology, announced today it will be hosting a Webinar titled, “Pathology is ... Advanced Pathology Associates , on digital pathology adoption best practices and how Proscia ...
Breaking Biology Technology: